InnoCan Pharma Corporation announced that it is has added Peter Bloch to its Board of Directors. Mr. Bloch is a Chartered Accountant with an extensive record of entrepreneurial and executive successes. He has held senior management positions with Sanofi-Aventis Canada, Intellivax International Inc., Gennum Corporation and Tribute Pharmaceuticals. Mr. Bloch is currently the CEO of Bresotec Inc. Mr. Bloch was previously CEO and Chairman of Bionik Laboratories and was a member of the Dean's Advisory Council at the Ted Rogers School of Management, Ryerson University.